Hani Abouhalka

Company Group Chairman, Surgical Technologies, Johnson & Johnson
· tracked since Jul 2026
Calls
1
Win Rate
0.0%
return
-0.5%
Calls 1 2 Posts tracked · 0.4/day
Calls
7d 1
30d 1
90d 1
Best Calls
No live winners yet
Worst Calls
JNJ Long -0.5%
Most Mentioned
JNJ ×2
Recent Calls
JNJ Long 4 days ago
Win Rate 0% Long 1 Short 0
Win Rate
7d
30d
90d
Average Return -0.5% Long Return -0.5% Short Return -
Average Return
7d
30d
90d
Loading charts...
Result
Result
Sort
Theme Stance
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Jul 31
$256.35
-0.5%
J&J's unique robotic surgery poised for growth
Johnson & Johnson's Ottava robotic surgery platform has a differentiated architecture (arms integrated into the table) that reduces operating room friction, while the robotic surgery market has only 8% penetration and is fast-growing. J&J expects its robotics business to become materially significant towards the end of the decade and aims to become a leader in surgical robotics.
Pharma & Biotech
Showing 1 of 1 calls · sorted by mentions

Hani Abouhalka has 1 trade ideas tracked on Buzzberg across 1 tickers since July 2026. Most covered: JNJ.